Chen, Lezong
Zheng, Yongqiang
Yu, Kai
Chen, Shuzhao
Wang, Weida http://orcid.org/0000-0002-8272-5421
Gale, Robert Peter http://orcid.org/0000-0002-9156-1676
Liu, Ze-Xian
Liang, Yang http://orcid.org/0000-0002-4226-9580
Funding for this research was provided by:
National Natural Science Foundation of China (81873428)
Sun Yat-sen University (201603)
Guangdong Innovative and Entrepreneurial Research Team Program (2017ZT07S096)
Article History
Received: 7 February 2022
Revised: 4 May 2022
Accepted: 5 May 2022
First Online: 16 May 2022
Competing interests
: RPG is a Consultant to BeiGene Ltd., CStone Pharmaceuticals and Kite Pharmma; a Consultant to Fusion Pharma LLC, LaJolla NanoMedical Inc. and Mingsight Parmaceuticals Inc.; an Advisory Board member for Antegene Biotech LLC and StemRad Ltd; Medical Director at FFF Enterprises Inc; Partner in AZACA Inc; and on the Board of Directors of the Russian Foundation for Cancer Research Support.